Harrow Stock News & Updates
[WKN: A2PBJD | Symbol: HROW]
Analysts' Top 5 Price Targets of July 14, 2025
Harrow Inc. [US4158581094] Cantor Fitzgerald starts coverage with Overweight and a price target of...
Analysts' Top 5 Price Targets of June 10, 2025
PureCycle Technologies [US74623V1035]: Alembic Global confirms Buy rating with a price target of $18...
Ophthalmology Specialist Harrow Revenue Grows by 84% in Q4 - A Game Changer
Harrow (HROW) is a pharmaceutical company specialized in ophthalmology based in the USA. The stock was...
Harrow in the Pivotal Point Check: Ophthalmology on the Rise – Q4 Revenues Nearly Doubled and Strong Forecast for 2025!
Harrow specializes in innovative ophthalmological therapies in ophthalmology. In the fourth quarter,...
Stocks in Action USA: Harrow, Sarepta Therapeutics, and Elbit Systems.
Harrow (HROW) – the MedTech company surprises with strong quarterly results – stock soaring! The...
Analysts at H.C. Wainwright Foresee Rapid Growth for Harrow (HROW), Driven by its Portfolio of Branded Ophthalmology Products. The Stock has Room for up to $57 (+85%)
Harrow (HROW) is a USA-based pharmaceutical company specialized in ophthalmology. After a sixfold increase...
TOP 5 Price Targets From Analysts on February 6, 2025
ArcelorMittal [LU1598757687]: Jefferies maintains rating at Buy with a price target of €33 (29% upside...
- ‹
- 1
- ›